ACRS Q2 2022 Earnings — Aclaris Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

ACRSAclaris Therapeutics, Inc.

$435M

Q2 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$2M-16.2% YoY

Gross Profit

$460,00030.1% margin

Operating Income

-$21M-1374.0% margin

Net Income

-$21M-1343.7% margin

EPS (Diluted)

$-0.25

QoQ Revenue Growth

+5.2%

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$278M

Total Liabilities

$42M

Stockholders' Equity

$236M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	-16.2%
Gross Profit	$460,000	$561,000	-18.0%
Operating Income	-$21M	-$18M	-16.6%
Net Income	-$21M	-$18M	-13.1%

Revenue Segments

Contract research

$1M80%

Other revenue

$310,00020%